Micromet (MITI) Company Profile

Home Company Profile Index Micromet (MITI) Company Profile

Last Updated by WikiWealth | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Analysis is Current Needs More Inputs

General Information

Name: Micromet
Website:
Phone:
Email:
Founded:
Employees:
Stage:
Location:

Address:

Industry / Market

Target:
Products:
Size:
Growth Rate: %
Other Info:

Management Team

Multi-Media

Web Presence

Images:

Documents:

Videos:

Main Profile

WikiWealth Investment Sponsors

Management Style Survey

Consistent strategy for > 5 yrs?

Business promotes from within?

Passionate about each endeavor?

Management avoids the spotlight?

Non-monetary core ideology?

Cult-like corporate culture?

Micromet, Inc., is a biopharmaceutical company. Headquartered in Bethesda, Maryland, Micromet develops antibodies for the treatment of cancer, inflammation, and autoimmune diseases. (see report summary)

---

Management Analysis Update

---

Micromet Milestones Update

---

Click here to see 's Discounted Cash Flow analysis.

Discuss Micromet

EDWARD OSLER (guest) 05 Jul 2011 21:08

THERE DOES NOT SEEM TO BE ANY RHYME OR REASON FOR THE GROWTH OF THIS STOCK AND NO AVAILABLE INFORMATION ON WHY IT IS ACTING THE WAY IT DOES. OVER THE LAST THREE MONTHS IT HAS PLAYED THE ELEVATOR GAME OF ANYWHERE BETWEEN $5.00 AND $8.00. IT GROWS OR DOES NOT GROW BASED ON THE WHIMS OF THE ECONOMY. MITI HAS A DRUG THAT CAN CURE VARIOUS FORMS OF CANCER. THE TRIALS HAVE BEEN SUCCESSFUL. PATIENTS HAVE GONE INTO REMISSION AND STAYED IN REMISSION AND YET THIS DRUG VASCILLATES.

WHY?

Post preview:

Close preview

	or Sign in as Wikidot user
	(will not be published)

- +

Help: wiki text quick reference

Other Profiles

These profiles are connected to Micromet (MITI) Company Profile: